(Q39470265)
Statements
Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts (English)
Celine Leteur
Tarig Bashir
Bruno Schoentjes
Janine Arts
Michel Janicot
Jean Bourhis
22 August 2011